240 related articles for article (PubMed ID: 19819870)
1. Functional roles of human kallikrein-related peptidases.
Sotiropoulou G; Pampalakis G; Diamandis EP
J Biol Chem; 2009 Nov; 284(48):32989-94. PubMed ID: 19819870
[TBL] [Abstract][Full Text] [Related]
2. Metastasis of ovarian cancer is mediated by kallikrein related peptidases.
Dong Y; Loessner D; Irving-Rodgers H; Obermair A; Nicklin JL; Clements JA
Clin Exp Metastasis; 2014 Jan; 31(1):135-47. PubMed ID: 24043563
[TBL] [Abstract][Full Text] [Related]
3. Kallikrein-related peptidases.
Lundwall A; Brattsand M
Cell Mol Life Sci; 2008 Jul; 65(13):2019-38. PubMed ID: 18344018
[TBL] [Abstract][Full Text] [Related]
4. Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical Application.
Fuhrman-Luck RA; Loessner D; Clements JA
EJIFCC; 2014 Oct; 25(3):269-81. PubMed ID: 27683474
[TBL] [Abstract][Full Text] [Related]
5. Kallikrein-related peptidase's significance in Alzheimer's disease pathogenesis: A comprehensive survey.
Boumali R; Urli L; Naim M; Soualmia F; Kinugawa K; Petropoulos I; El Amri C
Biochimie; 2024 Apr; ():. PubMed ID: 38608749
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Kallikrein-Related Peptidases in Nervous System Disorders.
Mella C; Figueroa CD; Otth C; Ehrenfeld P
Front Cell Neurosci; 2020; 14():166. PubMed ID: 32655372
[TBL] [Abstract][Full Text] [Related]
7. Unleashing the therapeutic potential of human kallikrein-related serine proteases.
Prassas I; Eissa A; Poda G; Diamandis EP
Nat Rev Drug Discov; 2015 Mar; 14(3):183-202. PubMed ID: 25698643
[TBL] [Abstract][Full Text] [Related]
8. Targeting the kallikrein-related peptidases for drug development.
Sotiropoulou G; Pampalakis G
Trends Pharmacol Sci; 2012 Dec; 33(12):623-34. PubMed ID: 23089221
[TBL] [Abstract][Full Text] [Related]
9. Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance.
Avgeris M; Mavridis K; Scorilas A
Biol Chem; 2012 Apr; 393(5):301-17. PubMed ID: 22505514
[TBL] [Abstract][Full Text] [Related]
10. Predictions for the future of kallikrein-related peptidases in molecular diagnostics.
Scorilas A; Mavridis K
Expert Rev Mol Diagn; 2014 Jul; 14(6):713-22. PubMed ID: 24927162
[TBL] [Abstract][Full Text] [Related]
11. Putative kallikrein substrates and their (patho)biological functions.
Yu Y; Prassas I; Diamandis EP
Biol Chem; 2014 Sep; 395(9):931-43. PubMed ID: 24854536
[TBL] [Abstract][Full Text] [Related]
12. Old genes and new genes: the evolution of the kallikrein locus.
Lundwall A
Thromb Haemost; 2013 Sep; 110(3):469-75. PubMed ID: 23571662
[TBL] [Abstract][Full Text] [Related]
13. Regulation of kallikrein-related peptidases in the skin - from physiology to diseases to therapeutic options.
Fischer J; Meyer-Hoffert U
Thromb Haemost; 2013 Sep; 110(3):442-9. PubMed ID: 23446429
[TBL] [Abstract][Full Text] [Related]
14. Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases.
Yoon H; Blaber SI; Li W; Scarisbrick IA; Blaber M
Biol Chem; 2013 Jan; 394(1):137-47. PubMed ID: 23241590
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there.
Pasic MD; Olkhov E; Bapat B; Yousef GM
Biol Chem; 2012 Apr; 393(5):319-30. PubMed ID: 22505515
[TBL] [Abstract][Full Text] [Related]
16. Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact.
Talieri M; Devetzi M; Scorilas A; Pappa E; Tsapralis N; Missitzis I; Ardavanis A
Tumour Biol; 2012 Aug; 33(4):1075-84. PubMed ID: 22351561
[TBL] [Abstract][Full Text] [Related]
17. Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).
Goettig P; Magdolen V; Brandstetter H
Biochimie; 2010 Nov; 92(11):1546-67. PubMed ID: 20615447
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs.
White NM; Bui A; Mejia-Guerrero S; Chao J; Soosaipillai A; Youssef Y; Mankaruos M; Honey RJ; Stewart R; Pace KT; Sugar L; Diamandis EP; Doré J; Yousef GM
Biol Chem; 2010 Apr; 391(4):411-23. PubMed ID: 20180642
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation.
Sotiropoulou G; Pampalakis G
Biol Chem; 2010 Apr; 391(4):321-31. PubMed ID: 20180637
[TBL] [Abstract][Full Text] [Related]
20. Deletion of Kallikrein-related peptidases (
Finnerty RM; Carulli EM; Bernhardt ML; Maddison LA; Winuthayanon W
MicroPubl Biol; 2024; 2024():. PubMed ID: 38344070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
